This favorable clinical behavior may be biologically explained by the role of TTF-1 in maintaining a more differentiated tumor phenotype and modulating key signaling pathways related to tumor proliferation and immune microenvironment interactions [9,12]. Here, TTF1 is linked to neoplasm.